A family history of malignancy is the only patient-specific factor associated with a significantly increased risk for cancer among patients with psoriatic disease treated with biologics vs topical ...
SAN CARLOS, Calif. and DALLAS, Oct. 23, 2025 /PRNewswire/ -- CAGE Bio Inc., a clinical-stage biotechnology company pioneering novel immunomodulatory therapies for dermatological diseases, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback